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Abstract: Following injury to peripheral nerves, Schwann cells dedifferentiate,
proliferate, migrate and, when axon regeneration occurs, redifferentiate into a
myelinating phenotype. Schwann cells promote regeneration through the
creation of a permissive environment for axon regrowth and the production of
neurotrophic factors. Neuregulin1 (NRG1) is a polymorphic factor involved in
the myelination and remyelination processes. Through three injury models, the
expression of different NRG1 isoforms and of their ErbB receptors was
investigated in the distal portion of the rat median nerve under degenerating
conditions (unrepaired cut nerve) or under regenerating conditions after a mild
(nerve crush) and more severe (end-to-end repair of cut nerve) injury.
Following peripheral nerve injury, distinct and consecutive phases occur: nerve
degeneration, axonal regrowth, nerve regeneration and maturation. A detailed
mRNA and protein expression analysis of the NRG1/ErbB system was carried
out, focusing the attention not only on soluble and transmembrane NRG1
isoforms, but also on alpha and beta as well as type a, b, and c isoforms.
Expression specificity during the distinct and consecutive phases occurring
after nerve injury and regeneration or the progress in nerve degeneration was
observed. Nerve ultrastructure changes were evaluated by electron microscopy
and related to the results of mRNA and protein expression analyses. At the
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mRNA level, soluble NRG1 isoforms alpha and beta, as well as type a and b,
are strongly up-regulated early, during nerve degeneration and the early phases
of axonal regrowth, but their expression does not seem to be differentially
regulated under regeneration and degeneration conditions. ErbB receptors are
strongly regulated in the different phases, but at the protein level ErbBs are
similarly regulated in the different injury models. On the contrary, we observed
that transmembrane NRG1 isoforms are differentially regulated, at the protein
level, under degeneration and regeneration conditions, thus suggesting that
their expression could be a good marker to follow and monitor the regeneration
process. This accurate regulation suggests that each member of the
NRG1/ErbB system plays a specific role following nerve injury, that could be
clinically exploited to promote nerve regeneration. This project has received
funding from the European Union’s Seventh Programme for research,
technological development and demonstration.
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